Found: 307
Select item for more details and to access through your institution.
Anatomic and Behavioral Aspects of Frontal-Subcortical Circuitsa.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 769, n. 1, p. 1, doi. 10.1111/j.1749-6632.1995.tb38127.x
- By:
- Publication type:
- Article
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia.
- Published in:
- Movement Disorders, 2010, v. 25, n. 6, p. 687, doi. 10.1002/mds.22799
- By:
- Publication type:
- Article
Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders.
- Published in:
- Movement Disorders, 2001, v. 16, n. 6, p. 1098, doi. 10.1002/mds.1225
- By:
- Publication type:
- Article
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 2, p. 509, doi. 10.3233/JAD-2010-1390
- By:
- Publication type:
- Article
Mary S. Easton Center of Alzheimer's Disease Research at UCLA: Advancing the Therapeutic Imperative.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 19, n. 2, p. 375, doi. 10.3233/JAD-2010-1286
- By:
- Publication type:
- Article
Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 1, p. 41, doi. 10.2165/11531270-000000000-00000
- By:
- Publication type:
- Article
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
- Published in:
- Alzheimer's Research & Therapy, 2022, p. 1, doi. 10.1186/s13195-022-01124-2
- By:
- Publication type:
- Article
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00813-8
- By:
- Publication type:
- Article
Topological reorganization of functional hubs in patients with Parkinson's disease with freezing of gait.
- Published in:
- Journal of Neuroimaging, 2023, v. 33, n. 4, p. 547, doi. 10.1111/jon.13107
- By:
- Publication type:
- Article
Using bibliometrics to evaluate outcomes and influence of translational biomedical research centers.
- Published in:
- Journal of Clinical & Translational Science, 2022, v. 6, n. 1, p. 1, doi. 10.1017/cts.2021.863
- By:
- Publication type:
- Article
Cortical Change in Alzheimer's Disease Detected with a Disease-specific Population-based Brain Atlas.
- Published in:
- Cerebral Cortex, 2001, v. 11, n. 1, p. 1, doi. 10.1093/cercor/11.1.1
- By:
- Publication type:
- Article
Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification.
- Published in:
- Drugs, 2023, v. 83, n. 15, p. 1387, doi. 10.1007/s40265-023-01938-w
- By:
- Publication type:
- Article
Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0300-8
- By:
- Publication type:
- Article
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0173-2
- By:
- Publication type:
- Article
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0122-5
- By:
- Publication type:
- Article
Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-014-0088-8
- By:
- Publication type:
- Article
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.
- Published in:
- Alzheimer's Research & Therapy, 2012, v. 4, n. 5, p. 43, doi. 10.1186/alzrt146
- By:
- Publication type:
- Article
Comparison of neuropsychological functioning in Alzheimer's disease and frontotemporal dementia.
- Published in:
- Journal of the International Neuropsychological Society, 1996, v. 2, n. 6, p. 505, doi. 10.1017/S1355617700001673
- By:
- Publication type:
- Article
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Health-related quality-of-life and service utilization in Alzheimer's disease: A cross-sectional study.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2000, v. 15, n. 2, p. 94, doi. 10.1177/153331750001500206
- By:
- Publication type:
- Article
Brain functional topology differs by sex in cognitively normal older adults.
- Published in:
- Cerebral Cortex Communications, 2022, v. 3, n. 3, p. 1, doi. 10.1093/texcom/tgac023
- By:
- Publication type:
- Article
A practical algorithm for managing Alzheimer's disease: what, when, and why?
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 3, p. 307, doi. 10.1002/acn3.166
- By:
- Publication type:
- Article
Overcoming obstacles to repurposing for neurodegenerative disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2014, v. 1, n. 7, p. 512, doi. 10.1002/acn3.76
- By:
- Publication type:
- Article
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Guidelines for Managing Alzheimer's Disease: Part II. Treatment.
- Published in:
- American Family Physician, 2002, v. 65, n. 12, p. 2525
- By:
- Publication type:
- Article
Guidelines for Managing Alzheimer's Disease: Part I. Assessment.
- Published in:
- American Family Physician, 2002, v. 65, n. 11, p. 2263
- By:
- Publication type:
- Article
COMMENTARY ON: L-METHYLFOLATE, METHYLCOBOLAMINE, AND N-ACETYLCYSTEINE IN THE TREATMENT OF ALZHEIMER'S DISEASE-RELATED COGNITIVE DECLINE.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
INTEGRATING SYMPTOMATIC-AND DISEASE-MODIFYING TREATMENTS.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. Suppl. 6, p. 28
- By:
- Publication type:
- Article
INTRODUCTION.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. Suppl. 6, p. 4
- By:
- Publication type:
- Article
The Black Book of Alzheimer's Disease, Part 2.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. 3, p. 69
- By:
- Publication type:
- Article
CREATIVITY AND DEMENTIA: EMERGING DIAGNOSTIC AND TREATMENT METHODS FOR ALZHEIMER'S DISEASE.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. Suppl. 1, p. 1
- By:
- Publication type:
- Article
UPDATE ON ALZHEIMER'S DISEASE: ONE HUNDRED YEARS AFTER DR. ALOIS ALZHEIMER.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. Suppl. 1, p. 4
- By:
- Publication type:
- Article
The Black Book of Alzheimer's Disease, Part 1.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. 2, p. 66
- By:
- Publication type:
- Article
Physostigmine in Wilson disease.
- Published in:
- 1978
- By:
- Publication type:
- case study
Subgroup Analysis of US and Non-US Patients in a Global Study of High-Dose Donepezil (23 mg) in Moderate and Severe Alzheimer’s Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Subgroup Analysis of US and Non-US Patients in a Global Study of High-Dose Donepezil (23 mg) in Moderate and Severe Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2012, v. 27, n. 6, p. 421, doi. 10.1177/1533317512454708
- By:
- Publication type:
- Article
Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2010, v. 25, n. 4, p. 347, doi. 10.1177/1533317510365344
- By:
- Publication type:
- Article
Evaluation of Dementia Rating Scales in Parkinson's Disease Dementia.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2010, v. 25, n. 2, p. 142, doi. 10.1177/1533317509333904
- By:
- Publication type:
- Article
Neuropsychiatric and Behavioral Symptoms in a Community Sample of Hispanics With Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2006, v. 21, n. 4, p. 263, doi. 10.1177/1533317506289350
- By:
- Publication type:
- Article
Geriatric Neuropsychopharmacology: Unmet Needs.
- Published in:
- Psychogeriatrics, 2001, v. 1, n. 1, p. 14, doi. 10.1111/j.1479-8301.2001.tb00069.x
- By:
- Publication type:
- Article
Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer’s disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET).
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12136
- By:
- Publication type:
- Article
Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020, v. 6, n. 1, p. 1, doi. 10.1002/trc2.12115
- By:
- Publication type:
- Article
Enrichment factors for clinical trials in mild‐to‐moderate Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 164, doi. 10.1016/j.trci.2019.04.001
- By:
- Publication type:
- Article
Neurodegeneration research: Advances in clinical translational neuroscience infrastructure and methods.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, v. 4, n. 1, p. 326, doi. 10.1016/j.trci.2018.03.008
- By:
- Publication type:
- Article
Advances in functional magnetic resonance imaging data analysis methods using Empirical Mode Decomposition to investigate temporal changes in early Parkinson's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, v. 4, n. 1, p. 372, doi. 10.1016/j.trci.2018.04.009
- By:
- Publication type:
- Article